Stempin S et al.Morphological and molecular characterization of the human breast epithelial cell line M13SV1 and its tumorigenic derivatives M13SV1-R2-2 and M13SV1-R2-N1.Cancer Cell Int 15:110 (2015).
Yew KH et al.Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum.PLoS One 8:e72637 (2013).
Guimaraes-Souza NK et al.In vitro reconstitution of human kidney structures for renal cell therapy.Nephrol Dial Transplant : (2012).
Ghosh SK et al.Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.Int J Cancer : (2012).
Miura Y et al.Glycoblotting-assisted O-glycomics: ammonium carbamate allows for highly efficient o-glycan release from glycoproteins.Anal Chem 82:10021-9 (2010).
Hughes OD et al.Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595.J Clin Oncol 18:363-70 (2000).
Denton G et al.Production and characterization of a recombinant anti-MUC1 scFv reactive with human carcinomas.Br J Cancer 76:614-21 (1997).
Denton G et al.Primary sequence determination and molecular modelling of the variable region of an antiMUC1 mucin monoclonal antibody.Eur J Cancer 31A:214-21 (1995).
Price MR et al.Purification of anti-epithelial mucin monoclonal antibodies by epitope affinity chromatography.J Immunol Methods 139:83-90 (1991).
Price MR et al.Immunological and structural features of the protein core of human polymorphic epithelial mucin.Mol Immunol 27:795-802 (1990).
Price MR et al.C595--a monoclonal antibody against the protein core of human urinary epithelial mucin commonly expressed in breast carcinomas.Br J Cancer 61:681-6 (1990).